Back to MORGAN STANLEY MORGAN STANLEY

EVGNEVGN
8 quarters

Position history for MORGAN STANLEYMORGAN STANLEY's holdings in EVOGENE LTD

Yes. Morgan Stanley holds 1,285 shares of EVGN (Evogene), worth $564, as of its Q2 2026 13F filing. It reduced the position by 2,566 shares (-66.6%) from Q1 2026. Morgan Stanley has held EVGN since Q3 2024, across 8 quarterly 13F filings.

Current Value

$564

Current Shares

1,285

Total Value Change

-$38,133

Total Shares Change

-11,320

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2026-Q2
Latest
Decreased
1,285
-66.6%
$5640.0%$0.44
0
2026-Q1
Decreased
3,851
-57.5%
$2,9650.0%$0.85
0
2025-Q4
Decreased
9,051
-70.2%
$9,9560.0%$0.94
0
2025-Q3
Increased
30,343
+99.8%
$34,6520.0%$1.18
22
2025-Q2
Increased
15,186
+4.1%
$19,4380.0%$1.30
13
2025-Q1
Unchanged
14,586
0.0%
$18,2320.0%$1.31
0
2024-Q4
Increased
14,586
+15.7%
$27,2760.0%$1.92
15
2024-Q3
New
12,605
-
$38,6970.0%$2.56
31

Other major holders of EVGN: CITADEL ADVISORS LLC, JANE STREET GROUP, LLC, HRT FINANCIAL LP

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used